Market open· · DKK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
NNIT AS (OCSE:NNIT) navigates a challenging quarter with strong margin recovery in the U.S. and robust Public Denmark growth, while advancing its AI platforms and strategic transformation.
Q2 2026 key highlights NNIT's financial performance was in line with initial expectations, despite continued customer caution, particularly within the life science segments. However, order entry improved during the quarter across all regions, supported by targeted growth initiatives aimed at strengthening sales execution. Reported group revenue declined 4.5% to DKK 441.6m, corresponding to constant currency revenue growth of -4.4%. The decline was primarily driven by the life science regions, wh
NNIT AS (STU:5NN) faces revenue declines but remains optimistic with new AI platforms and strategic initiatives to drive future growth.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.